Form D · Biotechnology
BioROSA Technologies Inc
Wayland, MA · CIK 0001781974
Offering snapshot reported Nov 30, 2022 · SEC filing
- Reported sold
- $745K Offering amount: $1.6M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 30, 2022 | Initial | $745,000 | No comparison | 8 | SEC filing |
| Jul 28, 2021 | Amendment | $2,431,250 | $1,851,250vs Jul 15, 2020 | 16 | SEC filing |
| Jul 15, 2020 | Initial | $580,000 | No comparison | 8 | SEC filing |
| Jul 10, 2019 | Initial | $450,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-466162
Source: Form D, filed Nov 30, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marie Causey | Director, Executive |
| Christopher Jeffers | Director, Executive |
| John Slattery | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
72 Sedgemeadow Road
Wayland, MA, 01778
Wayland, MA, 01778